Drug · DIN 00885975
VIVOTIF
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 14, 2024; first marketed January 1, 1993.
- Drug Identification Number (DIN)
- 00885975
- Company (DIN owner)
- Bavarian Nordic AsHellerup, Denmark
- Schedule
- Schedule D
- Dosage form
- Capsule (Enteric-Coated)
- Route
- Oral
- Therapeutic class (ATC)
- Typhoid, oral, live attenuated J07AP01
- Class
- Human
- Record last updated
- July 20, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SALMONELLA TYPHI TY21A LIVE ATTENUATED | 10000000000 CFU |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 27, 2023: NOC 32407New Drug Submission (NDS) · Administrative - Change in Product Ownership
- November 13, 2020: NOC 24644New Drug Submission (NDS) · Change in product ownerhsip
- May 7, 2020: NOC 23579New Drug Submission (NDS) · Manufacturer name change
- January 23, 2015: NOC 16567New Drug Submission (NDS) · Manufacturer name change
- March 16, 2010: NOC 11150New Drug Submission (NDS) · Manufacturer name change
- May 2, 2002: NOC 846New Drug Submission (NDS) · Manufacturer and product name change
- August 25, 1994: NOC 5598Supplement to a New Drug Submission (SNDS) · Revised product monograph